Preferred Name |
Nelarabine |
|
Synonyms |
|
|
Definitions |
An arabinonucleoside antimetabolite with antineoplastic activity. Nelarabine is demethoxylated by adenosine deaminase to become biologically active 9-beta-D-arabinosylguanine (ara-G); ara-G incorporates into DNA, thereby inhibiting DNA synthesis and inducing an S phase-dependent apoptosis of tumor cells. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C1704 |
|
Accepted_Therapeutic_Use_For |
T-cell Acute Lymphoblastic Leukemia; T-cell Lymphoblastic Lymphoma |
|
ALT_DEFINITION |
A drug used to treat certain types of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). It belongs to the family of drugs called antimetabolites. |
|
CAS_Registry |
121032-29-9 |
|
CHEBI_ID |
CHEBI:63612 |
|
Chemical_Formula |
C11H15N5O5 |
|
code |
C1704 |
|
Contributing_Source |
CTRP FDA |
|
definition |
An arabinonucleoside antimetabolite with antineoplastic activity. Nelarabine is demethoxylated by adenosine deaminase to become biologically active 9-beta-D-arabinosylguanine (ara-G); ara-G incorporates into DNA, thereby inhibiting DNA synthesis and inducing an S phase-dependent apoptosis of tumor cells. (NCI04) |
|
Display_Name |
Nelarabine |
|
FDA_UNII_Code |
60158CV180 |
|
Has_Target | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C176424 http://purl.obolibrary.org/obo/NCIT_C116977 http://purl.obolibrary.org/obo/NCIT_C116978 http://purl.obolibrary.org/obo/NCIT_C128784 |
|
Is_Value_For_GDC_Property | ||
label |
Nelarabine |
|
Legacy Concept Name |
Nelarabine |
|
Maps_To |
Nelarabine |
|
NCI_Drug_Dictionary_ID |
43260 |
|
NSC Number |
686673 |
|
PDQ_Closed_Trial_Search_ID |
43260 |
|
PDQ_Open_Trial_Search_ID |
43260 |
|
Preferred_Name |
Nelarabine |
|
prefixIRI |
NCIT:C1704 |
|
prefLabel |
Nelarabine |
|
Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide |
|
UMLS_CUI |
C0907349 |
|
subClassOf |